- FASTA Sequence
- PDBx/mmCIF Format
- PDBx/mmCIF Format (gz)
- BinaryCIF Format (gz)
- Legacy PDB Format
- Legacy PDB Format (gz)
- PDBML/XML Format (gz)
- Structure Factors (CIF)
- Structure Factors (CIF - gz)
- Validation Full (PDF - gz)
- Validation (XML - gz)
- Validation (CIF - gz)
- Validation 2fo-fc coefficients (CIF - gz)
- Validation fo-fc coefficients (CIF - gz)
- Biological Assembly 1 (CIF - gz)
- Biological Assembly 2 (CIF - gz)
- Biological Assembly 1 (PDB - gz)
- Biological Assembly 2 (PDB - gz)
2AJF | pdb_00002ajf
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor
- PDB DOI: https://doi.org/10.2210/pdb2AJF/pdb
- Classification: hydrolase/viral protein
- Organism(s): Homo sapiens, Severe acute respiratory syndrome-related coronavirus
- Expression System: Spodoptera frugiperda
- Mutation(s): No
- Deposited: 2005-08-01 Released: 2005-09-20
- Deposition Author(s): Li, F., Li, W., Farzan, M., Harrison, S.C.
Experimental Data Snapshot
- Method: X-RAY DIFFRACTION
- Resolution: 2.90 Å
- R-Value Free: 0.275 (Depositor), 0.305 (DCC)
- R-Value Work: 0.218 (Depositor)
- R-Value Observed: 0.221 (Depositor)
Starting Model: experimental
View more details
Literature
- 👁 Image
Download Mendeley
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.
Li, F., Li, W., Farzan, M., Harrison, S.C.(2005) Science 309: 1864-1868
- PubMed: 16166518 Search on PubMed
- DOI: https://doi.org/10.1126/science.1116480
- Primary Citation Related Structures:
2AJF - PubMed Abstract:
The spike protein (S) of SARS coronavirus (SARS-CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The crystal structure at 2.9 angstrom resolution of the RBD bound with the peptidase domain of human ACE2 shows that the RBD presents a gently concave surface, which cradles the N-terminal lobe of the peptidase. The atomic details at the interface between the two proteins clarify the importance of residue changes that facilitate efficient cross-species infection and human-to-human transmission. The structure of the RBD suggests ways to make truncated disulfide-stabilized RBD variants for use in the design of coronavirus vaccines.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Laboratory of Molecular Medicine, 320 Longwood Avenue, Boston, MA 02115, USA.
Organizational Affiliation:
Explore in 3D: Structure | Sequence Annotations | Electron Density | Validation Report | Ligand Interaction (NAG)
Biological Assembly 1
Explore in 3D: Structure | Sequence Annotations | Electron Density | Validation Report | Ligand Interaction (NAG)
Global Symmetry: Asymmetric - C1
Global Stoichiometry: Hetero 2-mer - A1B1
Find Similar Assemblies
Biological assembly 1 assigned by authors and generated by PISA (software)
Biological Assembly 2
Explore in 3D: Structure | Sequence Annotations | Electron Density | Validation Report | Ligand Interaction (NAG)
Global Symmetry: Asymmetric - C1
Global Stoichiometry: Hetero 2-mer - A1B1
Find Similar Assemblies
Biological assembly 2 assigned by authors and generated by PISA (software)
Macromolecule Content
- Total Structure Weight: 182.06 kDa
- Atom Count: 12,777
- Modeled Residue Count: 1,542
- Deposited Residue Count: 1,554
- Unique protein chains: 2
Macromolecules
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Angiotensin-converting enzyme-Related Carboxypeptidase (Ace2) | 597 | Homo sapiens | Mutation(s): 0 Gene Names: ACE2 EC: 3.4.17 (PDB Primary Data), 3.4.17.23 (UniProt) | 👁 Image | |
UniProt & NIH Common Fund Data Resources | |||||
PHAROS: Q9BYF1 GTEx: ENSG00000130234 | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | Q9BYF1 | ||||
Glycosylation | |||||
| Glycosylation Sites: 4 | Go to GlyGen: Q9BYF1-1 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| SARS-coronavirus spike protein | C [auth E], D [auth F] | 180 | Severe acute respiratory syndrome-related coronavirus | Mutation(s): 0 Gene Names: S | 👁 Image |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P59594 | ||||
Glycosylation | |||||
| Glycosylation Sites: 1 | Go to GlyGen: P59594-1 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
Oligosaccharides
HelpEntity ID: 3 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Length | 2D Diagram | Glycosylation | D Interactions |
| beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | E [auth C], F [auth D] | 3 | 👁 Image | N-Glycosylation | |
Glycosylation Resources | |||||
GlyTouCan: G15407YE GlyCosmos: G15407YE GlyGen: G15407YE | |||||
Small Molecules
Experimental Data & Validation
Experimental Data
- Method: X-RAY DIFFRACTION
- Resolution: 2.90 Å
- R-Value Free: 0.275 (Depositor), 0.305 (DCC)
- R-Value Work: 0.218 (Depositor)
- R-Value Observed: 0.221 (Depositor)
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 82.299 | α = 90 |
| b = 119.429 | β = 91.97 |
| c = 113.237 | γ = 90 |
| Software Name | Purpose |
|---|---|
| REFMAC | refinement |
| HKL-2000 | data reduction |
| SCALEPACK | data scaling |
| AMoRE | phasing |
Entry History
Deposition Data
- Released Date: 2005-09-20 Deposition Author(s): Li, F., Li, W., Farzan, M., Harrison, S.C.
Revision History (Full details and data files)
- Version 1.0: 2005-09-20
Type: Initial release - Version 1.1: 2008-04-30
Changes: Version format compliance - Version 1.2: 2011-07-13
Changes: Advisory, Version format compliance - Version 2.0: 2020-07-29
Type: Remediation
Reason: Carbohydrate remediation
Changes: Atomic model, Data collection, Derived calculations, Structure summary - Version 2.1: 2023-08-23
Changes: Data collection, Database references, Refinement description, Structure summary - Version 3.0: 2024-12-25
Changes: Advisory, Atomic model, Data collection, Derived calculations, Structure summary
